PharmAI provides cutting-edge software technology for drug discovery, specializing in chemoinformatics and structure analysis. Their services include focused library screening, scaffold diversification, and off-target identification, leveraging advanced AI methods combined with deep learning to optimize drug candidate predictions. With a knowledge-based approach, they analyze the geometry of protein binding sites and drug-target interactions, ensuring high precision and rapid turnarounds based on 3D protein structures and binding affinities. PharmAI's DiscoveryEngine processes vast chemical spaces efficiently, which allows for the identification of potential drug candidates and off-targets at an accelerated pace. Their commitment to delivering high-quality results is backed by extensive computational investments, making their platform a reliable partner for researchers in drug discovery.
• ai-driven predictions
• off-target identification
• high scaffold diversity
• focused library screening
• scaffold diversification
• rapid delivery of results
• systematic similarity screening
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
AI platform for drug discovery using advanced data analytics and machine learning.
View DetailsAI-powered platform for drug discovery using novel therapeutics and machine learning.
View DetailsAI-powered small molecule drug discovery platform accelerating drug development.
View DetailsCreate spooky beats online with this unique musical game featuring character-based sound mixing.
View Details